薬物動態
Print ISSN : 0916-1139
新規去痰薬Sodium5-(acetylamino)3,5-dideoxy-D-glycero-D-galacto-2-nonulosonate(KI-111)の体内動態(第3報):ラットにおける皮下反復投与
佐藤 雅樹矢野 三郎小笠原 定則
著者情報
ジャーナル フリー

1991 年 6 巻 2 号 p. 227-235

詳細
抄録
Accumulation and elimination of 14C-labelled Sodium 5-(acetylamino)-3, 5 dideoxy-D-glycero-D-galacto-2-nonulosonate (KI-111) were studied in rats after 7 or 14 repeated subcutaneous (s.c.) administration, by measurement of the tissue level and whole body autoradiography. At 15 minutes after final s. c. administration of the compound, the radioactivity was observed in all tissues and organs except the brain and spinal cord. High radioactivity was observed in the injected site, kidney and circulating blood. At 24 hours after administration, the radioactivity was observed in the injected site, kidney and intestine.
著者関連情報
© 日本薬物動態学会
前の記事 次の記事
feedback
Top